A Matrix Metalloproteinase Inhibitor Enhances Anti-Cytotoxic T Lymphocyte Antigen-4 Antibody Immunotherapy in Breast Cancer by Reprogramming the Tumor Microenvironment

Oncology Reports - Greece
doi 10.3892/or.2016.4547

Related search